136 related articles for article (PubMed ID: 36662872)
21. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
[TBL] [Abstract][Full Text] [Related]
23. Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer.
Chen F; Hui TSK; Ma L; Nong Y; Han Y; Jing H; Lee EKW; Xu Z; Fu P; Chang ATY; Hsue V; Kong FS
Front Oncol; 2022; 12():811794. PubMed ID: 35186748
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity.
Norkus D; Miller A; Kurtinaitis J; Haverkamp U; Popov S; Prott FJ; Valuckas KP
Strahlenther Onkol; 2009 Nov; 185(11):715-21. PubMed ID: 19899003
[TBL] [Abstract][Full Text] [Related]
25. Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.
Iyengar P; Zhang-Velten E; Court L; Westover K; Yan Y; Lin MH; Xiong Z; Patel M; Rivera D; Chang J; Saunders M; Shivnani A; Lee A; Hughes R; Gerber D; Dowell J; Gao A; Heinzerling J; Li Y; Ahn C; Choy H; Timmerman R
JAMA Oncol; 2021 Oct; 7(10):1497-1505. PubMed ID: 34383006
[TBL] [Abstract][Full Text] [Related]
26. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer.
Tallari RV; Singh OP; Yogi V; Yadav S
J Cancer Res Ther; 2017; 13(2):224-229. PubMed ID: 28643738
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis.
Park J; Yea JW; Park JW
Medicine (Baltimore); 2020 Oct; 99(42):e22721. PubMed ID: 33080729
[TBL] [Abstract][Full Text] [Related]
28. The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients.
Butler-Xu YS; Marietta M; Zahra A; TenNapel M; Mitchell M
Adv Radiat Oncol; 2019; 4(2):261-267. PubMed ID: 31011671
[TBL] [Abstract][Full Text] [Related]
29. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancerĀ (CRiSP): An international systematic review and meta-analysis.
Tchelebi LT; Lehrer EJ; Trifiletti DM; Sharma NK; Gusani NJ; Crane CH; Zaorsky NG
Cancer; 2020 May; 126(10):2120-2131. PubMed ID: 32125712
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.
Glaser SM; Dohopolski MJ; Balasubramani GK; Flickinger JC; Beriwal S
J Neurooncol; 2017 Aug; 134(1):107-118. PubMed ID: 28527010
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China.
Zhong QZ; Xia X; Gao H; Xu YG; Zhao T; Wu QH; Wang D; Lin HL; Sha XY; Liu M; Li GF
Aging (Albany NY); 2021 Feb; 13(5):6936-6944. PubMed ID: 33653964
[TBL] [Abstract][Full Text] [Related]
32. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
33. Comparison Between Stereotactic and Conventional Radiotherapy for Solitary Lung Tumor After Resection of Lung Cancer.
Takahashi S; Go T; Anada M; Kinoshita T; Nishide T; Yokomise H; Shibata T
Anticancer Res; 2019 Jun; 39(6):2957-2962. PubMed ID: 31177135
[TBL] [Abstract][Full Text] [Related]
34. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
Koshy M; Malik R; Weichselbaum RR; Sher DJ
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):344-50. PubMed ID: 25636759
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.
Yan SX; Qureshi MM; Dyer M; Truong MT; Mak KS
Lung Cancer; 2019 May; 131():147-153. PubMed ID: 31027693
[TBL] [Abstract][Full Text] [Related]
36. Comparing Hypofractionated With Conventional Fractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
Gu L; Dai W; Fu R; Lu H; Shen J; Shi Y; Zhang M; Jiang K; Wu F
Front Oncol; 2021; 11():753209. PubMed ID: 34660318
[TBL] [Abstract][Full Text] [Related]
37. A Retrospective Analysis of the Impact of HIV Infection on Outcomes of Locally Advanced Cervical Cancers Treated With Either Conventional or Hypofractionated Radiotherapy: The Uganda Experience.
Kavuma A; Luutu I; Kibudde S; Kanyike D
JCO Glob Oncol; 2022 Jun; 8():e2100360. PubMed ID: 35696625
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional conformal external-beam radiotherapy for localized prostate adenocarcinoma: a report on the first-year biochemical response.
Norkus D; Miller A; Plieskiene A; Janulionis E; Valuckas KP
Medicina (Kaunas); 2009; 45(6):469-75. PubMed ID: 19605967
[TBL] [Abstract][Full Text] [Related]
39. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma.
Merchant TE; Cahill JC; Ghavimi F
Med Pediatr Oncol; 1998 Jun; 30(6):332-8. PubMed ID: 9589081
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancer.
Mitera G; Swaminath A; Rudoler D; Seereeram C; Giuliani M; Leighl N; Gutierrez E; Dobrow MJ; Coyte PC; Yung T; Bezjak A; Hope AJ
J Oncol Pract; 2014 May; 10(3):e130-6. PubMed ID: 24643574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]